Liraglutide Use in Prader-Willi Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Liraglutide (Primary)
- Indications Prader-Willi syndrome; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 08 Dec 2015 Status changed from active, no longer recruiting to discontinued, as reported by ClinicalTrials.gov.
- 08 Mar 2012 New trial record